Ronald Blue Trust, Inc. Seagen Inc. Transaction History

Ronald Blue Trust, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$0.0 - $228.9 $0 - $3,433	15 Added 10.95%	152 $32,000
Q3 2023 Oct 11, 2023	BUY	$191.51 - $216.16 $1,915 - $2,161	10 Added 7.87%	137 $26,000
Q2 2023 Jul 14, 2023	SELL	$187.64 - $206.25 $4,315 - $4,743	-23 Reduced 15.33%	127 $25,000
Q1 2023 Apr 17, 2023	BUY	$127.59 - $203.08 $637 - $1,015	5 Added 3.45%	150 $19,000
Q4 2022 Jan 17, 2023	BUY	$117.37 - $139.17 $3,638 - $4,314	31 Added 27.19%	145 $20,000

Q3 2022 Oct 21, 2022	BUY	$135.27 - $180.11 $405 - $540	3 Added 2.7%	114 $20,000
Q2 2022 Aug 09, 2022	BUY	$108.81 - $179.33 $12,077 - $19,905	111 New	111 $16,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

Stay updated on Ronald Blue Trust, Inc. with notifications on news.